Literature DB >> 30066886

lncRNA GAS5 inhibits colorectal cancer cell proliferation via the miR‑182‑5p/FOXO3a axis.

Kangwen Cheng1, Zhenguo Zhao2, Guihe Wang3, Jian Wang1, Weiming Zhu1.   

Abstract

Long non‑coding RNAs (lncRNAs) are mainly involved in diverse biological processes in human malignancies. The expression profile and underlying mechanism of the lncRNA growth arrest specific transcript 5 (GAS5) in colorectal cancer (CRC) are poorly understood. Here, we investigated the role of GAS5 in human CRC tissues. lncRNA GAS5 was specifically downregulated in CRC tissues and cell lines. Reduced GAS5 levels were significantly associated with advanced clinical stage and lymph node metastasis in CRC. GAS5 overexpression suppressed CRC cell proliferation and promoted cellular apoptosis. A dual‑luciferase reporter assay showed that GAS5 could negatively regulate the expression of microRNA (miR)‑182‑5p. Upregulated miR‑182‑5p abrogated the effect of GAS5 overexpression on CRC cell proliferation and apoptosis. Furthermore, GAS5 positively regulated the expression of FOXO3a in CRC cells. Taken together, these findings suggest that overexpression of the lncRNA GAS5 inhibits cell proliferation and promotes apoptosis by inhibiting miR‑182‑5p expression, and thus could be a therapeutic target in CRC.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30066886     DOI: 10.3892/or.2018.6584

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  21 in total

1.  Comprehensive analysis of differentially expressed lncRNAs as diagnostic and prognostic markers for colorectal cancer.

Authors:  Xunlei Zhang; Xingsong Zhang; Lili Shen; Li Song; Jindong Wu; Guangxin Cao; Xin Chen; Bin Zhu
Journal:  Exp Ther Med       Date:  2019-09-30       Impact factor: 2.447

2.  Comprehensive analysis of DRAIC and TP53TG1 in breast cancer luminal subtypes through the construction of lncRNAs regulatory model.

Authors:  Jamshid Motalebzadeh; Elaheh Eskandari
Journal:  Breast Cancer       Date:  2022-07-24       Impact factor: 3.307

Review 3.  Apoptosis evasion via long non-coding RNAs in colorectal cancer.

Authors:  Muhammad Irfan; Zeeshan Javed; Khushbukhat Khan; Naila Khan; Anca Oana Docea; Daniela Calina; Javad Sharifi-Rad; William C Cho
Journal:  Cancer Cell Int       Date:  2022-09-08       Impact factor: 6.429

Review 4.  Research Progress of Long Non-Coding RNA GAS5 in Malignant Tumors.

Authors:  Guohong Lin; Tianzhun Wu; Xing Gao; Ziqin He; Wenwei Nong
Journal:  Front Oncol       Date:  2022-06-28       Impact factor: 5.738

Review 5.  Tumor Suppressive Effects of GAS5 in Cancer Cells.

Authors:  Jesminder Kaur; Nur'ain Salehen; Anwar Norazit; Amirah Abdul Rahman; Nor Azian Abdul Murad; Nik Mohd Afizan Nik Abd Rahman; Kamariah Ibrahim
Journal:  Noncoding RNA       Date:  2022-05-28

Review 6.  Research updates on the clinical implication of long noncoding RNA in digestive system cancers and chemoresistance.

Authors:  Xinzhi Miao; Fang Wang; Tianyun Wang; Siti Razila Abdul Razak; Muhammad Amir Yunus; Ida Shazrina Ismail
Journal:  3 Biotech       Date:  2021-09-01       Impact factor: 2.893

Review 7.  From inflammatory bowel disease to colorectal cancer: what's the role of miRNAs?

Authors:  Mostafa Vaghari-Tabari; Niloufar Targhazeh; Soheila Moein; Durdi Qujeq; Forough Alemi; Maryam Majidina; Simin Younesi; Zatollah Asemi; Bahman Yousefi
Journal:  Cancer Cell Int       Date:  2022-04-11       Impact factor: 5.722

8.  Whole transcriptome sequencing identifies crucial genes associated with colon cancer and elucidation of their possible mechanisms of action.

Authors:  Yang Yang; Yanan Zhao; Wenlong Zhang; Yuansong Bai
Journal:  Onco Targets Ther       Date:  2019-04-10       Impact factor: 4.147

Review 9.  LncRNAs as Regulators of Autophagy and Drug Resistance in Colorectal Cancer.

Authors:  Mercedes Bermúdez; Maribel Aguilar-Medina; Erik Lizárraga-Verdugo; Mariana Avendaño-Félix; Erika Silva-Benítez; Cesar López-Camarillo; Rosalío Ramos-Payán
Journal:  Front Oncol       Date:  2019-10-02       Impact factor: 6.244

10.  Novel Tumor Suppressor lncRNA Growth Arrest-Specific 5 (GAS5) In Human Cancer.

Authors:  Yaya Yu; Swei Sunny Hann
Journal:  Onco Targets Ther       Date:  2019-10-11       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.